CTS Eventim stock pre-market at EUR 57.25: unchanged
Published on 10/09/2026 at 07:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- CTS Eventim stock was unchanged at EUR 57.25 in pre-market trading at 7:48 a.m. CEST.
- The company lists November 12, 2026, for its Q3 quarterly communication.
- JPMorgan retained a EUR 95.00 price target and an Overweight rating on September 30, 2026.
CTS Eventim stock was unchanged at EUR 57.25 in pre-market trading at Lang & Schwarz on October 9, 2026, at 7:48 a.m. CEST. The quote was unchanged versus the prior close at Lang & Schwarz of EUR 57.25 on October 8, 2026.
Pre-market trading
The Lang & Schwarz bid was EUR 57.05 and the ask was EUR 57.45. With Xetra still closed, the unchanged indication provides the reference for investors ahead of the regular session. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of CTS Eventim stock.
What matters today
CTS Eventim's next scheduled reporting date is November 12, 2026, when the company lists publication of its Q3 quarterly communication in its investor-relations calendar. A round-number level of EUR 60.00 is 4.80 percent above the EUR 57.25 pre-market price. JPMorgan's September 30, 2026 assessment retained a EUR 95.00 target and an Overweight rating, according to Finanznachrichten.
Scheduled reporting
The November date is the next company-specific item listed on CTS Eventim's investor-relations page. It refers to the quarterly communication for the third quarter and is separate from the current market indication. The calendar also identifies the company as preparing a scheduled financial update rather than announcing a new operating measure in the pre-market session.
Analyst assessment
The JPMorgan item was published by dpa-AFX Analyser on September 30, 2026. The report said the bank kept both its Overweight rating and EUR 95.00 price target for CTS Eventim. This dated analyst view is presented separately from the Lang & Schwarz quote and does not establish a cause for the current unchanged indication.
Market context: Market report MDAX.
